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1. Introduction
  Over the past decade, there has been a significant increase 
in the incidence of tuberculosis (TB) worldwide[1]. Thirty-
two percent of the world’s populations (i.e., 1.86 billion 
people) are infected with Mycobacterium tuberculosis 
(M. tuberculosis). Most of these people have latent M. 
tuberculosis. In 1997, there were about 1.87 million deaths, 
with an average mortality rate of 23%. Nearly 500 000 die 
from the disease -more than 1 000 per day–one every 
minute[2]. The incident is high in Africa, with 290 cases per 
100 000 populations[3], although the greatest prevalence is in 
the most populous countries, such as India, Bangladesh and 
Pakistan. Each year, 636 000 new incident cases(80%) occur 
in the top 23 TB countries[4]. TB is the second commonest 
cause of death world wide[5]. In some African countries the 
mortality rate was as high as 50%[4]. The large majority of 
the cases and deaths are from the poor nations. Tuberculosis 
(TB) continues to remain one of the most pressing health 
problems in India. India is the highest TB burden country in 
the world, accounting for one fifth of the global incidence - 
an estimated 1.96 million cases annually[1]. Approximately 2.9 
million people die from tuberculosis each year worldwide; 
about one fifth of them in India alone[1].
  Most forms of active TB can be treated with six months of 
medication.  Unfortunately, the very success of the drug 
treatment of tuberculosis has been the catalyst for the 
emergence of a new wave of drug resistance. Beginning in 
1990, outbreaks of multi drug resistant (MDR) tuberculosis 
have been reported in hospitals and prisons in the eastern 
United States[6]. It has been estimated that 3.2% of the 
world’s new cases of TB, in 2000, were MDR-TB, defined as 
resistant to at least  isoniazid and rifampicin[7]. Tuberculosis 
patients in part of Eastern Europe and Central Asia are 10 
times more likely to have MDR-TB than in the rest of the 
world according to a World Health Organization (WHO) 
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report into the deadly infectious disease, China, Ecuador, 
Israel and South Africa are also identified as key areas. 
WHO’s leading infectious disease experts estimates there 
are 300 000 new cases per year of MDR-TB worldwide. The 
association with HIV and increasing MDR-TB appears to be 
a serious issue, especially for the developing nations. In 
addition, approximately 12% (226 000) of deaths from TB was 
attributed  to co-infected with M. tuberculosis and human 
immuno deficiency virus (TB-HIV). 
  Natural products form one avenue in the search for new 
antituberculosis agents. Nature has continuously provided 
humankind with a broad and structurally diverse of 
pharmacologically active compounds that continue to be 
utilized as highly effective drug to compact a multitude of 
deadly diseases. Natural products and their derivatives have 
traditionally been the most common source of drugs, and 
still represent more than 30% of the current pharmaceutical 
market[8]. It has long been recognized that natural product 
structures have the characteristics of high chemical 
diversity, biochemical specificity, and other molecular 
properties that make them favorable as lead structures for 
drug discovery, and which serve to differentiate them from 
libraries of synthetic and combinational compounds. 
  The oceans are the source of a large group of structurally 
unique natural products that are mainly accumulated 
in marine organisms. Several of these compounds show 
pronounced pharmacological activities and are interesting 
candidates for new drugs primarily in the area of cancer 
treatment. Other compounds are currently being developed 
as an analgesic or to treat inflammation. Among the 
many phyla found in the oceans, the best source of 
pharmacologically active compounds are bacteria (including 
cyanobacteria), fungi, certain group of algae, sponges, soft 
corals and gorgonians. Prokaryotic and eukaryotic micro 
algae produce a wide array of compounds with biological 
activities. These include antibiotics, algicides, toxins, 
pharmaceutically active compounds and growth regulators. 
The micro algal toxins is either important as material for 
useful drugs or one of the great mysteries in the world of 
biotoxicology.
  Recently, microalge have become targets for screening 
programmers in search of novel compounds of potential 
medicinal value[9]. Numerous compounds have been isolated 
from prokaryotic and eukaryotic microalgae, and have been 
tested for different types of bioactivity with positive effects. 
The future role of micro algal compounds in drug discovery 
is especially in the priority areas for the development of new 
medicines, namely to fight viral infections and cancer, and 
to combat infections from antibiotic resistant bacteria and 
fungi. Discovering new therapeutic molecules is becoming 
increasingly important as more and more bacteria resistant 
to the usual antibiotics. Traditionally used asiatic medicines, 
algae, since the second half of the 20th century, are screened 
for their biological activities. Thus, antibacterial effects have 
been noticed in all the algal classes[10-13]. However, most 
of these antibiotic actions have only been tested against 
human pathogens and the active molecules were rarely 
purified. The role of marine algae in the discovery of drugs 
which could reach the pharmaceutical market has increased 
notably in recent years, due to substantial improvement in 
biological screening methods. Only a small percentage of 
the microbial species have been examined and explored 
thoroughly for their pharmaceutical potential. Considering 
these aspects the current study was initiated.
2. Materials and methods
2.1. Collection and identification of MDR M. tuberculosis
  The morning sputum samples were collected from 351 
patients includes male and female patients from the 
Kanyakumari District Medical college hospital (formerly 
Government Chest Disease Hospital) Asaripallam, Tamil 
Nadu, India in the month of September 2002 with chest 
symptoms. Sputum samples were collected early morning 
before meal in a sterile wide mouth screw capped bottle 
free from antiseptics without contamination of saliva. The 
samples collected were labeled and transported to the 
laboratory immediately.
  Specific pathogens present in the samples collected 
from the patients were undergone culture technique 
and identified based on standard procedures. Initial 
identification and classification of smears was done by 
Ziehl-Neelson staining. Smear was prepared from the thick 
purulent part of the sputum using a new slide. Smear was 
dried, heat fixed and stained by Ziehl - Neelson technique. 
The smear was covered with strong carbol fuchsin and 
gently heated for 7 minutes, without letting the stain boil 
and become dry. The slide was then decanted, washed with 
sterile water and decolorized with acid alcohol (3% HCl in 
95% ethanol). After washing, the smear was counter stained 
with Loffler’s methylene blue for one minute. The acid-fast 
bacilli were seen on bright red rods and the smears were 
classified based on their numbers.
  The remaining sputum samples were immediately 
concentrated by Petroff’s method to separate Bacilli from 
sputum. The sputum was incubated with an equal volume 
of 4% sodium hydroxide at 37 曟 with frequent shaking till 
it becomes clear on an average for 20 minutes. It was then 
centrifuged at 3 000 rpm for 30 minutes and the sediment 
was neutralized with 10 N HCl and used for smear and 
culture technique. The concentrated samples were used for 
further studies.
  The concentrated materials were incubated into two bottles 
of IUAT - LJ medium and were incubated at 37 曟 for 3 
weeks. Finally, the bottles were examined and the isolated 
bacterial species were identified based on Bergey’s Manual 
of Determinative Bacteriology[14]. Species confirmation by 
16S rDNA analysis
2.2. Sensitivity check by commercial antimycobacterial drugs
  Sensitivity test of M. tuberculosis against commonly used 
front line and second line drugs were carried out by absolute 
concentration method using LJ Slant Kit (Hi media). 
This was to determine in vitro antibacterial susceptibility 
for commercially available anti tuberculosis drugs like 
streptomycin, ciprofloxacin, amikacin, ethionamide, 
isoniazide, ethanbutol, P. aminosaalicilic acid, pyrazinamide 
and rifambicin. Bacteria that are resistant to antibiotic 
show growth on the LJ slants which consist of specific anti-
tuberculosis drug after incubation at 37 曟 for 3 weeks. 
Bacteria which are sensitive show no growth on LJ slants. 
The isolated organisms showed resistance against more than 
one antimycobacterial drugs in Absolute Concentration 
methods were considered as MDR M. tuberculosis. The 
resistant bacteria were isolated and used for further 
screening producers.
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2.3. Culture of marine micro algae
  Algal inoculum of Isocrysis galbana (I. galbana), 
Nannochloropsis occulata (N. occulata), Dicarteria inorta(D. 
inorta) , Chromulina friebergensis (C. friebergensis), 
Chlorella marina (C. marina), Tetraselmis gracilis (T. 
gracilis) , Pavlova lutheri(P. lutheri), Chlorella salina, 
Chlorella vulgaris, Dunaliella saline, Spirulina platensis, 
Platymonas spp ,  Synechocysti salina (S. salina) , 
Nannochloropsis salina (N. salina) and Chlorella ovalis (C. 
ovalis) for the present study obtained from Central Marine 
Fisheries Research Institute (CMFRI) in Tuticorin, Tamil 
Nadu, India. 
  For stock culture the autoclaved or heated seawater after 
cooling was poured to the conical flasks and required 
nutrients are added. Walne’s medium enriched with 
vitamins is the ideal one to maintain the stock cultures of 
all the phytoflagellates. About 10 percent of the inoculums 
in the growing phase were transferred to the culture flasks 
and the same is placed in front of the tube light (1 000 lux). 
After 8-10 days. When the maximum exponential phase 
was reached, light was reduced for further growth. The time 
required for the maximum cell densities varies depending 
on the species. Almost all flagellates require 2 weeks for the 
completion of growth phase before entering into the decline 
phase. In the stationary phase, the flagellates can be kept 
for a period of 2 months in the stock culture room, under 
controlled condition of light and temperature. At the time 
of maximum exponential phase of growth the colour the 
turns into dark brown and the cells are found as suspension 
without movement. The cells of flagellates emerge out for its 
further growth and multiplication. A minimum of 5 culture 
flasks were kept for each species as stock culture.
  For mass culture filtered seawater was sterilized by 
autoclaving and after cooling to room temperature; 200 mL 
was poured into each conical flask. Prior to sterilization, 
salinity and pH was checked by refractormeter and pH 
meter respectively. The filtered sterilized seawater is 
enriched with required quantity of Walne’s medium. Then 
20 mL of the inoculums in the growing phase was transferred 
to the culture flask with 200 mL medium. Finally the 
culture flasks were placed in front of tube lights of 100 
lux. The temperature ranged from 28-33 曟. From the time 
of inoculation, samples were taken and fixed with the help 
of formalin for the measurement of cell density. The initial 
count was calculated before inoculation. After inoculation 
the cell count was calculated for every 2 days and was 
tabulated. Cell density was determined with a Neubauer 
haemocytometer. Duplicates were also made and cell 
density was recorded for alternative days.
2.4. Preparation of algal extract
  Algal cells in exponential growth phase were recovered 
from culture by batch centrifugation at 3 000 rpm for 10 
minutes. The cells were repeatedly washed in haemal 
saline for three times by centrifugation at low speed and 
there pellets were dried at 60 曟 for 24 hours. The resultant 
algal pellets were equally distributed in 5 tubes and stored 
in refrigerator till extraction process. The quantity of algal 
cells was measured. According to the methods of Khan[15] 
the mehonol extract to be prepared dry algal mass (ratio 
1:15g/mL) was extracted by ultra sonication and kept it 
for 24 hours. After the extraction phase being separated 
by centrifuged at 10 000 rpm for 15 min, this method was 
used for the ethanol, n-Butanol, chloroform and water 
respectively. Finally supernatants were collected and 
were dried under reduced pressure. All the extracts were 
preserved at +4 曟 for further investigation.  
2.5. In vitro screening against bacterial isolates with marine 
micro algal extracts 
  In vitro screening experiments with algal extract were carried 
out by absolute concentration method. Each 100 毺g of dried 
algal extracts of different solvent were taken and mixed 
with 5 mL sterile  L-J medium (Hi-media) and poured in 
the appropriate culture bottles and solidified in slanting 
position. On the LJ medium slant, the isolates of M. 
tuberculosis were inoculated and incubated at 37 曟 for 
more than four weeks, control bottles were maintained along 
with the test culture bottles. Proper aeration and was given 
in an aseptic condition through out the incubation. After 
the incubation, bottles were observed for colony formation. 
Positive and negative growths were noted and were recorded. 
2.6. Tube dilution technique
  Colonies were scrapped from a freshly growing (3 to 4 
weeks) Lowenstein- Jensen medium slant into 3 mL of 
middle brooks 7H9 broth containing four to  five 3 mm 
diameter glass beads  in a conical   tube. The tubes were 
vortexed vigorously for 3 to 5 min to homogenize the 
suspension. The large particles were allowed to settle, and 
the supernatant was adjusted to turbidity equivalent a 0.5 
Mc Farland. The increasing concentration of the three algal 
active principles were mixed with a series of culture tubes 
contains Middle Brooks 7H9 broth base (with ADC growth 
suppliment-Hi media) inoculated with the M. tuberculosis 
at 37 曟 for 4 weeks. After the incubation the growth of 
the organisms was scanned at 620 nm and the result were 
recorded. Slides were prepared from each tube for acid fast 
staining. No organisms other than acid fast bacilli were 
observed.
2.7. Preliminary biochemical analysis of active principles 
from chosen extracts
  Phytochemical tests were carried on the aqueous 
ethanolic extracts using standard procedures to identify the 
constituents as described by Sofowara[16].
2.8. Separation of sterols
  The algae are extracted with chloroform-methanol (2:1) and 
the extracts were filtered and concentrated under reduced 
pressure, yielding a green viscous residue. The green 
viscous residue was refluxed for 4 h with 7% methanolic 
potassium hydroxide. The solvent was removed in vacuum, 
water is added, and the residue was extracted with ether. 
Evaporation of ether leaves the NSF which is dissolved in 
light petroleum and chromatographed on a silica gel column 
(height 15 cm; diameter 1.5 cm). The stationary phase is 
a powdered silica gel, which is placed in a vertical glass 
column. The mixture to be analyzed is loaded on top of 
this column. The mobile phase is a solvent poured on top 
of the loaded column. The solvent flows down the column, 
causing the components of the mixture to distribute between 
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the powdered adsorbent. Thus the solvent separate the 
components of the mixture, when the solvent flows out of 
the bottom of the column, some components elute with early 
collections and other components elute with late fractions. 
The compounds are eluted with 40 mL of each of the 
following concentrations of light petroleum in benzene, 10, 
25, 50% (v/v), followed by ether and 25% methanol in ether, 
and finally with 20% methanol in chloroform. The fractions 
(15 mL each) are evaporated to dryness.
2.9. Efficacy check with different fractions
  The eluted fractions were screened against bacterial 
isolates by agar diffusion method. 100 毺g of evaporated 
fractions were incorporated in the 5 mL sterile L-J medium 
(Hi-media) and poured in the appropriate culture bottles 
and solidified in slanting position. On the slant, the isolates 
of M. tuberculosis were inoculated and incubated at 37 曟for 
more than four weeks, control bottles were maintained along 
with the test culture bottles. 
2.10. Compound characterization preparative thin layer 
chromatography and GC/MS
  Examination of each fraction by qualitative TLC (on silica 
gel GC-254, developing with light petroleum-ethyl ether 
-acetic acid, 20:4:1, and spraying with 50% H2SO4, and 
charring at 180 曟), reveal the presence of sterols at Rf0.43. 
The sterol fractions are pooled and subjected to preparative 
thin-layer chromatography (PTLC). The zones of sterols are 
scraped off the plates, extracted with chloroform-ethyl ether 
(1:1), and used for further experiments.
  Gas chromatography-mass spectrometry(GC/ms) analysis 
of an active principles was done by A Finnigan 400 
quadrupole mass spectrometer interfaced with Finnigan gas 
chromatograph with a DB - 5 column was used. Temperature 
programming at 4 曟/min to 280 曟. followed by 2 曟/min 
to 310 曟. Em voltage 1 500 V, electron energy 70eV; source 
temperature 240 曟. The compounds are identified by means 
of mass spectrometric comparison with standards and by co 
injection of authentic samples.
3. Results
  As a first step towards the development of novel 
phycochemicals against MDR-TB an intensive study was 
carried out by taking the samples of the patients with chest 
symptoms. 361 patients’ general proforma were collected 
includinggeneral symptoms like continuous fever, night 
sweat, loss of appetite, progressive weight loss, fatigue, 
weakness, chills, and chest symptoms like prolonged cough, 
blood tinged sputum, chest pain. The sputum was collected 
in the morning in sterile disposable cardboard boxes before 
any meal. The collected 361 samples throughout the month 
were subjected to direct microscopical examination and 
culture technique separately based on the result obtained 
from direct microscopical examination by Ziehl Neelson 
staining technique. 
  Sixty seven patients were found TB positive including 
30 males and 37 females among the infected ones. The 
concentration of bacilli in sputum was identified by taking 
the smear count. Out of 67 patients 49 were identified 
as 1+ (3 -9 bacilli seen in entire smear), 15 as 2+  (10 or 
more bacilli seen in the smear), the rest in the 3 patients 
fell under the category  of  3+ (10 or more bacilli seen in 
single field). The remaining portion of the sputum was used 
for culture technique after the concentration of sputum by 
petroff’s method. The concentrated materials of 361 patients 
were inoculated in to two bottles of IUAT LJ medium and were 
incubated at 37 曟. As a result colonies were started appearing 
from the fourth week onwards. It was found that at the end of 
six months colonies are formed only in 67 samples against 361. 
The obtained colonies were yellowish, elevated, wrinkled and 
dried. The remaining samples were confirmed negative. 
  The presence of M. tuberculosis was confirmed by 16S rDNA 
analysis. From the bacterial isolates the total DNA were 
extracted by the help of DNA isolation kits (Geni). Isolated 
DNA was subjected to PCR amplification. The forward 
primer used was 5’TGGCTCAGATTGAACGCTGGCGGC 3’ and 
the reverse primer was 5’TACCTTGTTACGACTTCACCCCA 3’. 
The PCR conditions were maintained in denaturation at 
95 曟 for 30 seconds, primer annealing at 50 曟 for 30 
seconds, polymerization at 71 曟 for 1 min and final 
extension at 71 曟for 10 minutes. These steps were repeated 
for 30 cycles in a thermocycler. The amplified product was 
subjected to agarose gel electrophoresis and the amplified 
16S rDNA band was observed under UV transilluminator. 
Finally, amplified product was sequenced by direct sequencing 
method. The obtained sequence contained 1 500 bp and it was 
confirmed through BLAST search and multiple sequence alignment 
algorithms. 
  Sensitivity test of 67 bacterial isolates against commercially 
used front line and second line drugs were carried out by 
absolute concentration method using LJ slants kit- 023 & 
024 (Hi media). This was to determine in vtiro antibacterial 
susceptibility for front line antibacterial drugs like 
isoniazide (0.2 毺g/mL), streptomycin (4 毺g/mL), ethambutol 
(2 毺g/mL), rifambicin (40 毺g/mL), pyrazinamide (200 毺
g/mL) and second line drugs like kanamycin (30 毺g/mL), 
amikacin (700 毺g/mL), ethinomide (20 毺g/mL), d-cyloserine 
(30 毺g/mL), clarithomycin (8 毺g/mL), ciprofloxacin
(12.5 毺g/mL), ρ-Amino salicylic acid (2.5 毺g/mL), 
Rifabutin (0.5 毺g/mL). The bacterial isolates numbered 
I-78, I-101, I-127, I-173, I-202, I-262, I-327 showed resistant 
for more than 3 drugs among front line and for some 
drugs in second line. These 7 isolates were considered as 
MDR M. tuberculosis (Table 1). Thus the percentage of 10.4 
were recorded MDR-TB for the month of September 2002. 
The screening of antibacterial compounds from chosen 
marine micro algal extract and partial characterization of 
active principles behind the antimycobacterial extracts 
were elucidated with 15 algal inoculums of I. galbana, N. 
occulata, D. inorta, C.  friebergensis, C. marina, T. gracilis, 
P. lutheri, C. salina, C. vulgaris, D. saline, C. calcitrans, 
Platymonas spp,  S. salina, N. salina, C. ovalis were obtained 
from Central Marine Fisheries Research Institute (CMFRI) at 
Tuticorin, South India. 
  The cultures were maintained in laboratory in Walne’s 
medium as stock culture. From the stock culture, they 
were mass cultured in sterile seawater containing Walne’s 
medium with proper aeration and light. The growth pattern 
were given in Table 2. Five different polar and non polar 
solvents were used for extraction of active principles. They 
were ethanol, n-butanol, chloroform, methanol and water. 
Each 100 毺g of dried algal extract of different solvents 
were taken and mixed with 5 mL of sterile LJ medium and 
pored in the appropriate culture bottles. On the slant, the 
isolates of M. tuberculosis were inoculated and incubated at 
37 曟 for more than 4 weeks, control bottles were maintained 
along with the test culture bottles. The 7 bacterial isolates 
of M. tuberculosis screened for the bioactive compounds 
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extracted from marine micro algae using different solvents 
(75 extracts). The percentage contribution of marine micro 
algal species on the extraction of antimicrobials indicated 
Isochrysis galbana which contain rich bioactive compounds 
accounted for 50% inhibition of the total isolates, while 
Chromulina friebergensis and Tetraselmis gracilis account 
for 17% and 33% seperately. The percentage contribution of 
solvents on the extraction of antimicrobials from Isochrysis 
galbana showed that the methanol, chloroform, n-butanol 
showed maximum of extraction of 33%, 50% and 17%, higher 
than that of other solvents tested. 
  The next algae showed the maximum percentage inhibition 
was T. gracilis accounting for 40% of the total isolates. The 
percentage contribution of solvents on the extraction of 
antimicrobials from T. gracilis showed that the chloroform 
and methanol showed maximum of extraction than the other 
solvents. The third alga with rich bioactive compound was 
C. friebergenesis with about 20% inhibition. The percentage 
contribution of solvents on the extraction of antimicrobials 
from C. friebergenesis showed that the chloroform showed 
maximum of extraction than the other algae. The rest of the 
other algae showed no inhibition towards isolates (Table 3). 
  The tube dilution technique used to determine the 
concentration dependent growth pattern of 3 algal active 
principles. The increasing concentration of dried algal 
extract were mixed in a series of culture tubes contains 
Middle Brooks 7H9 broth base (with ADC growth supplement 
-Hi Media) inoculated with the M. tuberculosis at 37  曟 for 
4 weeks. After the incubation the growth of the organism 
was scanned at 620 nm and the result were recorded. The 
result showed that the minimum inhibitory concentration of 
I. galbana was found to be 50-60毺g against M. tuberculosis 
for T. gracilis it was 70-80 毺g and for C. fribergensis it was 
80-90 毺g. 
  Primary phycochemical screening of active three algal 
showed the presence of sterols, fixed oils and fats etcs 
(Table 4). The active solvent extracts were then subjected 
to column chromatography and the collected fractions 
were subjected to bacterial screening procedures.  The 
NSF of active principle was dissolved in light petroleum 
and chromatographed  on a silica gel column (height 15 
cm diameter 1.5 cm) the compounds are eluted with 40 mL 
of each of the following concentration of light petroleum 
in benzene 10, 20, 50% (v/v), followed by ether and 25% 
methanol in chloroform. The fractions (15 mL each) were 
evaporated to dryness. Examination of each fraction by 
qualitative TLC (on silica gel GC 254 developing with light 
petroleum - ethyl ether-acetic acid, 20:4:1, and sprayed with 
50% H2SO4 and charring at 180 曟) revealed the presence 
of sterols at Rf 0.43. The sterol fractions are pooled and 
subjected to preparative thin layer chromatography (PTLC). 
The zones of sterols are scraped off the plates and extracted 
with chloroform-ethyl ether (1:1). Finally compounds were 
confirmed by gas chromatography.
Table 1
 Sensitivity pattern of isolated MDR M. tuberculosis against various commercially available anti TB drugs.
Chemotherapeutic Agents Symbol
Bacterial isolates
I-78 I-101 I-127 I-173 I-202 I-262 I-327
Streptomycin          Sm S R R R R R R
Ciprofloxacin          Cf S S S S S S S
Amikacin          Ak R R R R R R R
Ethionamide          Et S S S S S S S
Isoniazide          I R R R R R R R
Ethambutol          Eb S S S S S S S
p-aminosalicilic acid          Ps S R R R R R R
Pyrazinamide          Pz S S S S S S S
Rifambicin          R R R R R R R R
R-Resistant, S-Sensitive.
Table 2
Growth status of marine micro algal species in walney’s medium for every two days.
Days
Micro algal species (Number of cells 伊104)
A-1 A-2 A-3 A-4 A-5 A-6 A-7 A-8 A-9 A-10 A-11 A-12 A-13 A-14 A-15
Initial   36   60   40     5   10   12    4 16   19    25 15     4    7   70   65 
2nd day   55  130   80   15   27   25    9 49   53   46 48   10   14 130 110 
4th day   80 230 170   45   57   56   15 105 103   70 91   21   25 250 199 
6th day 145 425 260   65   95 101   22 150 193 100 156   42   50 475 312 
8th day 225 640 360   80 125 230   44 200 275 135 196   67   80 645 581 
10th day 290 805 460   95 360 333 101 298 370 150 255   98 111 880 700 
12th day 480 875 500 120 330 283 145 275 490 175 245 120 126 790 680 
14th day 600 880 520 215 301 253 199 265 375 201 230 135 145 710 603 
16th day 720 798 540 460 290 233 204 240 250 220 212 150 160 660 589 
A-1:  Isocrysis galbana, A-2:  Nannochloropsis occulata,  A-3: Dicarteria inorta,  A-4:  Chromulina  friebergensis,  A-5:  Chlorella marina
A-6: Tetraselmis gracilis, A-7: Pavlova lutheri,  A-8:  Chlorella salina,  A-9: Chlorella vulgaris,  A-10: Dunaliella saline, A-11: Chaetoceros 
calcitrans, A-12:  Platymonas spp,   A-13: Synechocysti salina,  A-14:  Nannochloropsis salina, A-15: Chlorella ovalis.
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  The purified eluted compounds (Rf 0.43) from TLC plate 
were chromatographed by gas chromatography Hewlette-
Packard 5890(series II) with an HP-GC mass selective 
detector (5971 MSD) (Figure 1). The sterol composition of 
eluted compound showed thirteen unsaturated sterols 
with three major sterols such as 24-oxocholesterol acetate 
(18.9%), Ergost-5-en-3 β-ol (16.2%) and Cholest-5-en-24-
1,3-(acetyloxy)-, 3β-ol (11.2%) (Table 5). 
Table 3
Sensitivity pattern of MDR M. tuberculosis isolates against marine microalgal extracts.
Sl. No Name of the micro algae Solvent Used
Bacterial isolates
I-78 I-101  I-127 I-173 I-202 I-262 I-327 control
1. Tetraselmis gracilis Ethanol - - - - - - - -
n-Butanol - - - - - - - -
Chloroform + + + + + + + +
Methanol + + + + + + + +
Water - - - - - - - -
2. Isochrysis galbana Ethanol - - - - - - - -
n-Butanol + + + + + + + +
Chloroform + + + + + + + +
Methanol + + + + + + + +
Water - - - - - - - -
3. Chromulina friebergenesis Ethanol - - - - - - - -
n-Butanol - - - - - - - -
Chloroform + + + + + + + +
Methanol - - - - - - - -
Water - - - - - - - -
-: No Inhibition;   +: Inhibition
Table 4
Preliminary phytochemical screening of selected crude marine micro algal extracts.
Active 
principles
Sterols Terperiods Carbohydrates Flavanoids Proteins Alkaloids Glycosides Tannins Saponins Phenols
Fixed oil 
and fats
MG-2 + - + - + - - - - - +
MG-6 + - + - + - - - + - +
MG-10 + - + - + - - - - - +
(+) Positive, (-) Negative.
Table 5
Natural sterols isolated from I. galbana.
Peak No. Compound Retention time (min) Molar mass (Da) Abundance (%)
1 Unidentified 107.35 428   3.1
2 Unidentified 107.39 428   5.5
3 Cholest-5-en-24-1,3-(acetyloxy)-, 3毬-ol 107.44 426 11.2
4 Ergost-5-en-3 毬-ol 112.22 400 16.2
5 (24R)-methylergost-5-en-3毬-ol 112.64 400   3.6
6 5毩-ergosta-7-en-3毬-ol 113.22 400   2.9
7 ergosta-5,7-dien-3毬-ol 114.09 398   6.3
8 ergosta-5,22(E)-dien-3毬-ol 115.20 398   2.6
9 24-oxocholesterol acetate 115.28 386 18.9
10 5毩-ergosta-7,22(z)-dien-3 毬-ol 115.39 398   5.3
11 24-methylcholesta-5,22-dien-3 毬-ol 115.45 398   9.4
12 ergosta-4,7,22-trien-3毬-ol 117.07 396   4.1
13 ergosta-5,7,22(E)-trien-3毬-ol 117.84 396   4.9
14 24-methylcholest-5-en-3毬-ol 118.74 396   6.3
15 ergosta-5,7,22,24(28)-tetraen-3毬-ol 120.38 394   2.7
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Figure 1. GC-MS chromatogram of natural sterols isolated from I. 
galbana
4. Discussion
  The test organisms are based on the choice of their 
Ubiquitous presence[17]. While screening with commercially 
available antibiotics shows that the human pathogens 
were multidrug resistant. In the present study the MDR M. 
tuberculosis were screened for bioactives extracted from 
marine microalgae with various solvents, it shows I. galbana 
has maximum activity. This is supported by the earlier 
studies of Lazarus and Valentinbhimba[18], who reported 
that I. galbana has rich bioactive compounds (10.8%). Present 
study reveals that the crude extracts of I. galbana solvent in 
chloroform showed better antimicrobials than other solvents. 
This clearly indicates that the strength of active principle 
depends on the use of suitable solvent. A thin layer 
chromatography fractionation of the extracts and further GS 
MS analysis suggested the active principle compound. 
  The present study indicates the presence of unsaturated 
fatty acids may have the effect on MDR M. tuberculosis, 
indicating a potential natural alternative to antibiotics. 
However, the limited number of test organisms owes to a 
constraint of resource. So the effect of strong bursts of micro 
algal extracts on human pathogenic bacteria should further 
be tested on a wide range of test organisms. 
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